Zynerba Pharmaceuticals, Inc. logo

Zynerba Pharmaceuticals, Inc.

Pioneering the development & commercialization of next-generation pharmaceutically-produced cannabinoid therapeutics formulated for transdermal delivery.

[stock_market_widget type=”leaderboard” template=”color-frame” color=”yellow” assets=”ZYNE” api=”yf” style=”font-size: 15px”]

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://zynerba.com
Disease Focus
Development Stage
STOCK CODENASDAQ: ZYNE
Address
80 W. Lancaster Avenue Suite 300, PA 19333
Devon
United States
Email
Contact Number
+1 484-581-7505

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/zynerba-pharmaceuticals” connections=”true” suffix=””]